Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2

135Citations
Citations of this article
135Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The efficacy of boron neutron capture therapy relies on the selective delivery of boron carriers to malignant cells. p-Boronophenylalanine (BPA), a boron delivery agent, has been proposed to be localized to cells through transporter-mediated mechanisms. In this study, we screened aromatic amino acid transporters to identify BPA transporters. Human aromatic amino acid transporters were functionally expressed in Xenopus oocytes and examined for BPA uptake and kinetic parameters. The roles of the transporters in BPA uptake were characterized in cancer cell lines. For the quantitative assessment of BPA uptake, HPLC was used throughout the study. Among aromatic amino acid transporters, ATB0,+, LAT1 and LAT2 were found to transport BPA with Km values of 137.4 ± 11.7, 20.3 ± 0.8 and 88.3 ± 5.6 μM, respectively. Uptake experiments in cancer cell lines revealed that the LAT1 protein amount was the major determinant of BPA uptake at 100 μM, whereas the contribution of ATB0,+ became significant at 1000 μM, accounting for 20-25% of the total BPA uptake in MCF-7 breast cancer cells. ATB0,+, LAT1 and LAT2 transport BPA at affinities comparable with their endogenous substrates, suggesting that they could mediate effective BPA uptake in vivo. The high and low affinities of LAT1 and ATB0,+, respectively, differentiate their roles in BPA uptake. ATB0,+, as well as LAT1, could contribute significantly to the tumor accumulation of BPA at clinical dose.

References Powered by Scopus

Towards a knowledge-based Human Protein Atlas

1966Citations
N/AReaders
Get full text

Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98)

980Citations
N/AReaders
Get full text

Boron neutron capture therapy of cancer: Current status and future prospects

936Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Amino acid transporters revisited: New views in health and disease

325Citations
N/AReaders
Get full text

The human SLC7A5 (LAT1): The intriguing histidine/large neutral amino acid transporter and its relevance to human health

212Citations
N/AReaders
Get full text

Boron neutron capture therapy (BNCT): a unique role in radiotherapy with a view to entering the accelerator-based BNCT era

209Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Wongthai, P., Hagiwara, K., Miyoshi, Y., Wiriyasermkul, P., Wei, L., Ohgaki, R., … Kanai, Y. (2015). Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2. Cancer Science, 106(3), 279–286. https://doi.org/10.1111/cas.12602

Readers over time

‘15‘16‘17‘18‘19‘20‘21‘22‘23‘24‘2507142128

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 26

49%

Researcher 16

30%

Professor / Associate Prof. 8

15%

Lecturer / Post doc 3

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 15

35%

Chemistry 11

26%

Agricultural and Biological Sciences 9

21%

Biochemistry, Genetics and Molecular Bi... 8

19%

Save time finding and organizing research with Mendeley

Sign up for free
0